XML 16 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Cash flows from operating activities:    
Net income (loss) including noncontrolling interests $ 8,398 $ (8,430)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation 5,249 5,315
Amortization of operating lease right-of-use assets 1,389 1,347
(Income) loss from equity method investments (570) 477
Dividends received from equity method investee   2,005
Interest income from investments (15) (125)
Deferred income tax 20 (1,748)
Stock based compensation expense 291 39
Gain on sale of property and equipment – net (3) (3)
Changes in assets and liabilities:    
Accounts receivable (7,844) 10,197
Inventories 11,193 8,366
Other assets (2,187) (3,759)
Accounts payable, trade (989) (11,934)
Other liabilities (1,369) (2,008)
Net cash provided by (used in) operating activities 13,563 (261)
Cash flows from investing activities:    
Capital expenditures (1,267) (4,700)
Purchases of short-term investments (25,930) (19,237)
Maturities of short-term investments 26,275 12,834
Other 30 (278)
Net cash used in investing activities (892) (11,381)
Cash flows from financing activities:    
Treasury stock acquired   (3,923)
Payments to noncontrolling interests holders (75) (35)
Capital contributions from minority investor 68 10
Net cash used in financing activities (7) (3,948)
Net increase (decrease) in cash, cash equivalents and restricted cash 12,664 (15,590)
Cash, cash equivalents and restricted cash, beginning of period 146,158 180,771
Cash, cash equivalents and restricted cash, end of period 158,822 165,181
Non cash investing activities – Accrued capital expenditures 280 457
Non cash financing activities – Stock awards accrued 348  
Right-of-use assets acquired and liabilities incurred upon lease execution   1,863
Cash and cash equivalents 157,105 163,771
Restricted cash $ 1,717 $ 1,410